nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivaroxaban—CYP3A4—type 2 diabetes mellitus	0.234	1	CbGaD
Rivaroxaban—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0514	0.114	CbGbCtD
Rivaroxaban—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0458	0.102	CbGbCtD
Rivaroxaban—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0386	0.0857	CbGbCtD
Rivaroxaban—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0331	0.0736	CbGbCtD
Rivaroxaban—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0308	0.0684	CbGbCtD
Rivaroxaban—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0274	0.061	CbGbCtD
Rivaroxaban—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0251	0.0558	CbGbCtD
Rivaroxaban—CYP3A5—Losartan—type 2 diabetes mellitus	0.0238	0.0529	CbGbCtD
Rivaroxaban—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0228	0.0506	CbGbCtD
Rivaroxaban—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0219	0.0488	CbGbCtD
Rivaroxaban—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0198	0.0441	CbGbCtD
Rivaroxaban—ABCB1—Glyburide—type 2 diabetes mellitus	0.017	0.0377	CbGbCtD
Rivaroxaban—ABCB1—Losartan—type 2 diabetes mellitus	0.0155	0.0345	CbGbCtD
Rivaroxaban—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.015	0.0334	CbGbCtD
Rivaroxaban—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0144	0.032	CbGbCtD
Rivaroxaban—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0144	0.032	CbGbCtD
Rivaroxaban—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0136	0.0303	CbGbCtD
Rivaroxaban—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0102	0.0226	CbGbCtD
Rivaroxaban—CYP3A4—Losartan—type 2 diabetes mellitus	0.00929	0.0206	CbGbCtD
Rivaroxaban—CYP2J2—artery—type 2 diabetes mellitus	0.00298	0.218	CbGeAlD
Rivaroxaban—F10—cardiovascular system—type 2 diabetes mellitus	0.00126	0.0924	CbGeAlD
Rivaroxaban—CYP2J2—nephron tubule—type 2 diabetes mellitus	0.00115	0.0843	CbGeAlD
Rivaroxaban—F10—adipose tissue—type 2 diabetes mellitus	0.00111	0.0815	CbGeAlD
Rivaroxaban—CYP2J2—cardiovascular system—type 2 diabetes mellitus	0.00103	0.0757	CbGeAlD
Rivaroxaban—F10—liver—type 2 diabetes mellitus	0.00078	0.0571	CbGeAlD
Rivaroxaban—CYP2J2—liver—type 2 diabetes mellitus	0.00064	0.0468	CbGeAlD
Rivaroxaban—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.000503	0.0368	CbGeAlD
Rivaroxaban—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.000405	0.0297	CbGeAlD
Rivaroxaban—CYP3A5—kidney—type 2 diabetes mellitus	0.000356	0.0261	CbGeAlD
Rivaroxaban—CYP3A5—pancreas—type 2 diabetes mellitus	0.000354	0.0259	CbGeAlD
Rivaroxaban—CYP3A5—cortex of kidney—type 2 diabetes mellitus	0.000347	0.0254	CbGeAlD
Rivaroxaban—CYP3A5—adipose tissue—type 2 diabetes mellitus	0.000321	0.0235	CbGeAlD
Rivaroxaban—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000267	0.0196	CbGeAlD
Rivaroxaban—CYP3A4—kidney—type 2 diabetes mellitus	0.000267	0.0196	CbGeAlD
Rivaroxaban—ABCB1—retina—type 2 diabetes mellitus	0.000229	0.0167	CbGeAlD
Rivaroxaban—CYP3A5—liver—type 2 diabetes mellitus	0.000225	0.0165	CbGeAlD
Rivaroxaban—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000215	0.0158	CbGeAlD
Rivaroxaban—ABCB1—cardiovascular system—type 2 diabetes mellitus	0.000193	0.0142	CbGeAlD
Rivaroxaban—ABCB1—kidney—type 2 diabetes mellitus	0.000189	0.0139	CbGeAlD
Rivaroxaban—ABCB1—pancreas—type 2 diabetes mellitus	0.000188	0.0138	CbGeAlD
Rivaroxaban—ABCB1—cortex of kidney—type 2 diabetes mellitus	0.000184	0.0135	CbGeAlD
Rivaroxaban—ABCB1—adipose tissue—type 2 diabetes mellitus	0.000171	0.0125	CbGeAlD
Rivaroxaban—CYP3A4—liver—type 2 diabetes mellitus	0.000169	0.0124	CbGeAlD
Rivaroxaban—Oedema—Valsartan—type 2 diabetes mellitus	0.000161	0.00078	CcSEcCtD
Rivaroxaban—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000161	0.000779	CcSEcCtD
Rivaroxaban—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00016	0.000778	CcSEcCtD
Rivaroxaban—Infection—Valsartan—type 2 diabetes mellitus	0.00016	0.000775	CcSEcCtD
Rivaroxaban—Rash—Glipizide—type 2 diabetes mellitus	0.00016	0.000775	CcSEcCtD
Rivaroxaban—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000159	0.000774	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000159	0.000773	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000159	0.000771	CcSEcCtD
Rivaroxaban—Oedema—Orlistat—type 2 diabetes mellitus	0.000159	0.000771	CcSEcCtD
Rivaroxaban—Headache—Glipizide—type 2 diabetes mellitus	0.000159	0.00077	CcSEcCtD
Rivaroxaban—Shock—Valsartan—type 2 diabetes mellitus	0.000158	0.000768	CcSEcCtD
Rivaroxaban—Infection—Orlistat—type 2 diabetes mellitus	0.000158	0.000766	CcSEcCtD
Rivaroxaban—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000158	0.000765	CcSEcCtD
Rivaroxaban—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000158	0.000765	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000157	0.000762	CcSEcCtD
Rivaroxaban—Hepatitis—Ramipril—type 2 diabetes mellitus	0.000157	0.000762	CcSEcCtD
Rivaroxaban—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000156	0.000759	CcSEcCtD
Rivaroxaban—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000156	0.000758	CcSEcCtD
Rivaroxaban—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000156	0.000758	CcSEcCtD
Rivaroxaban—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000156	0.000757	CcSEcCtD
Rivaroxaban—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000156	0.000756	CcSEcCtD
Rivaroxaban—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000156	0.000756	CcSEcCtD
Rivaroxaban—Urticaria—Glyburide—type 2 diabetes mellitus	0.000155	0.000751	CcSEcCtD
Rivaroxaban—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000155	0.000751	CcSEcCtD
Rivaroxaban—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000154	0.000749	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000154	0.000748	CcSEcCtD
Rivaroxaban—Back pain—Losartan—type 2 diabetes mellitus	0.000154	0.000748	CcSEcCtD
Rivaroxaban—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000154	0.000748	CcSEcCtD
Rivaroxaban—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000154	0.000748	CcSEcCtD
Rivaroxaban—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000153	0.000743	CcSEcCtD
Rivaroxaban—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000153	0.000742	CcSEcCtD
Rivaroxaban—Chest pain—Metformin—type 2 diabetes mellitus	0.000153	0.000741	CcSEcCtD
Rivaroxaban—Malaise—Irbesartan—type 2 diabetes mellitus	0.000153	0.000741	CcSEcCtD
Rivaroxaban—Headache—Pioglitazone—type 2 diabetes mellitus	0.000152	0.000738	CcSEcCtD
Rivaroxaban—Syncope—Irbesartan—type 2 diabetes mellitus	0.000152	0.000737	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000152	0.000736	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000151	0.000733	CcSEcCtD
Rivaroxaban—Discomfort—Metformin—type 2 diabetes mellitus	0.000151	0.000732	CcSEcCtD
Rivaroxaban—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000151	0.000732	CcSEcCtD
Rivaroxaban—Nausea—Glipizide—type 2 diabetes mellitus	0.00015	0.00073	CcSEcCtD
Rivaroxaban—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00015	0.000729	CcSEcCtD
Rivaroxaban—Hypotension—Valsartan—type 2 diabetes mellitus	0.00015	0.000729	CcSEcCtD
Rivaroxaban—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00015	0.000727	CcSEcCtD
Rivaroxaban—Constipation—Gliclazide—type 2 diabetes mellitus	0.00015	0.000726	CcSEcCtD
Rivaroxaban—Pain—Gliclazide—type 2 diabetes mellitus	0.00015	0.000726	CcSEcCtD
Rivaroxaban—Rash—Glimepiride—type 2 diabetes mellitus	0.000149	0.000723	CcSEcCtD
Rivaroxaban—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000149	0.000722	CcSEcCtD
Rivaroxaban—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000149	0.000722	CcSEcCtD
Rivaroxaban—Rash—Sitagliptin—type 2 diabetes mellitus	0.000149	0.000721	CcSEcCtD
Rivaroxaban—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000148	0.00072	CcSEcCtD
Rivaroxaban—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000148	0.00072	CcSEcCtD
Rivaroxaban—Headache—Glimepiride—type 2 diabetes mellitus	0.000148	0.000718	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000148	0.000717	CcSEcCtD
Rivaroxaban—Headache—Sitagliptin—type 2 diabetes mellitus	0.000148	0.000716	CcSEcCtD
Rivaroxaban—Anaemia—Losartan—type 2 diabetes mellitus	0.000147	0.000715	CcSEcCtD
Rivaroxaban—Oedema—Metformin—type 2 diabetes mellitus	0.000146	0.000711	CcSEcCtD
Rivaroxaban—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000146	0.000708	CcSEcCtD
Rivaroxaban—Angioedema—Losartan—type 2 diabetes mellitus	0.000146	0.000706	CcSEcCtD
Rivaroxaban—Infection—Metformin—type 2 diabetes mellitus	0.000145	0.000706	CcSEcCtD
Rivaroxaban—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000144	0.0007	CcSEcCtD
Rivaroxaban—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000144	0.000699	CcSEcCtD
Rivaroxaban—Shock—Metformin—type 2 diabetes mellitus	0.000144	0.000699	CcSEcCtD
Rivaroxaban—Malaise—Losartan—type 2 diabetes mellitus	0.000144	0.000697	CcSEcCtD
Rivaroxaban—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000144	0.000697	CcSEcCtD
Rivaroxaban—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000144	0.000697	CcSEcCtD
Rivaroxaban—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000143	0.000696	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000143	0.000695	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000143	0.000694	CcSEcCtD
Rivaroxaban—Syncope—Losartan—type 2 diabetes mellitus	0.000143	0.000693	CcSEcCtD
Rivaroxaban—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000142	0.000691	CcSEcCtD
Rivaroxaban—Skin disorder—Metformin—type 2 diabetes mellitus	0.000142	0.00069	CcSEcCtD
Rivaroxaban—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000142	0.000688	CcSEcCtD
Rivaroxaban—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000142	0.000687	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000141	0.000686	CcSEcCtD
Rivaroxaban—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000141	0.000684	CcSEcCtD
Rivaroxaban—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000141	0.000684	CcSEcCtD
Rivaroxaban—Nausea—Glimepiride—type 2 diabetes mellitus	0.00014	0.000681	CcSEcCtD
Rivaroxaban—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.00014	0.00068	CcSEcCtD
Rivaroxaban—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00014	0.000679	CcSEcCtD
Rivaroxaban—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.00014	0.000679	CcSEcCtD
Rivaroxaban—Asthenia—Glyburide—type 2 diabetes mellitus	0.00014	0.000679	CcSEcCtD
Rivaroxaban—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000139	0.000675	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000139	0.000674	CcSEcCtD
Rivaroxaban—Fatigue—Valsartan—type 2 diabetes mellitus	0.000139	0.000673	CcSEcCtD
Rivaroxaban—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000138	0.000671	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000138	0.000671	CcSEcCtD
Rivaroxaban—Oedema—Irbesartan—type 2 diabetes mellitus	0.000138	0.000671	CcSEcCtD
Rivaroxaban—Pruritus—Glyburide—type 2 diabetes mellitus	0.000138	0.000669	CcSEcCtD
Rivaroxaban—Constipation—Valsartan—type 2 diabetes mellitus	0.000137	0.000667	CcSEcCtD
Rivaroxaban—Infection—Irbesartan—type 2 diabetes mellitus	0.000137	0.000666	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000137	0.000666	CcSEcCtD
Rivaroxaban—Fatigue—Orlistat—type 2 diabetes mellitus	0.000137	0.000665	CcSEcCtD
Rivaroxaban—Hypotension—Metformin—type 2 diabetes mellitus	0.000137	0.000664	CcSEcCtD
Rivaroxaban—Shock—Irbesartan—type 2 diabetes mellitus	0.000136	0.00066	CcSEcCtD
Rivaroxaban—Pain—Orlistat—type 2 diabetes mellitus	0.000136	0.000659	CcSEcCtD
Rivaroxaban—Chest pain—Losartan—type 2 diabetes mellitus	0.000136	0.000658	CcSEcCtD
Rivaroxaban—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000136	0.000658	CcSEcCtD
Rivaroxaban—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000135	0.000658	CcSEcCtD
Rivaroxaban—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000135	0.000654	CcSEcCtD
Rivaroxaban—Rash—Bromocriptine—type 2 diabetes mellitus	0.000134	0.000652	CcSEcCtD
Rivaroxaban—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000134	0.000652	CcSEcCtD
Rivaroxaban—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000134	0.000651	CcSEcCtD
Rivaroxaban—Discomfort—Losartan—type 2 diabetes mellitus	0.000134	0.00065	CcSEcCtD
Rivaroxaban—Headache—Bromocriptine—type 2 diabetes mellitus	0.000134	0.000648	CcSEcCtD
Rivaroxaban—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000133	0.000647	CcSEcCtD
Rivaroxaban—Dry mouth—Losartan—type 2 diabetes mellitus	0.000133	0.000644	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000131	0.000638	CcSEcCtD
Rivaroxaban—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000131	0.000637	CcSEcCtD
Rivaroxaban—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000131	0.000635	CcSEcCtD
Rivaroxaban—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000131	0.000633	CcSEcCtD
Rivaroxaban—Oedema—Losartan—type 2 diabetes mellitus	0.00013	0.000631	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.00013	0.000631	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.00013	0.00063	CcSEcCtD
Rivaroxaban—Infection—Losartan—type 2 diabetes mellitus	0.000129	0.000627	CcSEcCtD
Rivaroxaban—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000129	0.000627	CcSEcCtD
Rivaroxaban—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000129	0.000626	CcSEcCtD
Rivaroxaban—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000129	0.000625	CcSEcCtD
Rivaroxaban—Shock—Losartan—type 2 diabetes mellitus	0.000128	0.000621	CcSEcCtD
Rivaroxaban—Urticaria—Valsartan—type 2 diabetes mellitus	0.000128	0.00062	CcSEcCtD
Rivaroxaban—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000127	0.000619	CcSEcCtD
Rivaroxaban—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000127	0.000617	CcSEcCtD
Rivaroxaban—Tachycardia—Losartan—type 2 diabetes mellitus	0.000127	0.000616	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000127	0.000615	CcSEcCtD
Rivaroxaban—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000127	0.000615	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000126	0.000613	CcSEcCtD
Rivaroxaban—Fatigue—Metformin—type 2 diabetes mellitus	0.000126	0.000613	CcSEcCtD
Rivaroxaban—Urticaria—Orlistat—type 2 diabetes mellitus	0.000126	0.000612	CcSEcCtD
Rivaroxaban—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000126	0.000609	CcSEcCtD
Rivaroxaban—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000126	0.000609	CcSEcCtD
Rivaroxaban—Constipation—Metformin—type 2 diabetes mellitus	0.000125	0.000608	CcSEcCtD
Rivaroxaban—Angioedema—Ramipril—type 2 diabetes mellitus	0.000125	0.000606	CcSEcCtD
Rivaroxaban—Vomiting—Glyburide—type 2 diabetes mellitus	0.000124	0.000601	CcSEcCtD
Rivaroxaban—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000124	0.000601	CcSEcCtD
Rivaroxaban—Malaise—Ramipril—type 2 diabetes mellitus	0.000123	0.000598	CcSEcCtD
Rivaroxaban—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000123	0.000598	CcSEcCtD
Rivaroxaban—Rash—Glyburide—type 2 diabetes mellitus	0.000123	0.000596	CcSEcCtD
Rivaroxaban—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000123	0.000596	CcSEcCtD
Rivaroxaban—Syncope—Ramipril—type 2 diabetes mellitus	0.000122	0.000595	CcSEcCtD
Rivaroxaban—Headache—Glyburide—type 2 diabetes mellitus	0.000122	0.000592	CcSEcCtD
Rivaroxaban—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000122	0.00059	CcSEcCtD
Rivaroxaban—Hypotension—Losartan—type 2 diabetes mellitus	0.000121	0.00059	CcSEcCtD
Rivaroxaban—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000121	0.000585	CcSEcCtD
Rivaroxaban—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.00012	0.000583	CcSEcCtD
Rivaroxaban—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.00012	0.000581	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.00012	0.000581	CcSEcCtD
Rivaroxaban—ABCB1—liver—type 2 diabetes mellitus	0.00012	0.00875	CbGeAlD
Rivaroxaban—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000119	0.000579	CcSEcCtD
Rivaroxaban—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000119	0.000578	CcSEcCtD
Rivaroxaban—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000118	0.000575	CcSEcCtD
Rivaroxaban—Constipation—Irbesartan—type 2 diabetes mellitus	0.000118	0.000573	CcSEcCtD
Rivaroxaban—Pain—Irbesartan—type 2 diabetes mellitus	0.000118	0.000573	CcSEcCtD
Rivaroxaban—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000117	0.000568	CcSEcCtD
Rivaroxaban—Urticaria—Metformin—type 2 diabetes mellitus	0.000116	0.000564	CcSEcCtD
Rivaroxaban—Chest pain—Ramipril—type 2 diabetes mellitus	0.000116	0.000564	CcSEcCtD
Rivaroxaban—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000116	0.000563	CcSEcCtD
Rivaroxaban—Nausea—Glyburide—type 2 diabetes mellitus	0.000116	0.000562	CcSEcCtD
Rivaroxaban—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000116	0.000562	CcSEcCtD
Rivaroxaban—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000116	0.000562	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000115	0.000561	CcSEcCtD
Rivaroxaban—Asthenia—Valsartan—type 2 diabetes mellitus	0.000115	0.00056	CcSEcCtD
Rivaroxaban—Discomfort—Ramipril—type 2 diabetes mellitus	0.000115	0.000558	CcSEcCtD
Rivaroxaban—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000114	0.000555	CcSEcCtD
Rivaroxaban—Asthenia—Orlistat—type 2 diabetes mellitus	0.000114	0.000553	CcSEcCtD
Rivaroxaban—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000114	0.000553	CcSEcCtD
Rivaroxaban—Pruritus—Valsartan—type 2 diabetes mellitus	0.000114	0.000552	CcSEcCtD
Rivaroxaban—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000114	0.000552	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000113	0.000548	CcSEcCtD
Rivaroxaban—Pruritus—Orlistat—type 2 diabetes mellitus	0.000112	0.000545	CcSEcCtD
Rivaroxaban—Fatigue—Losartan—type 2 diabetes mellitus	0.000112	0.000544	CcSEcCtD
Rivaroxaban—Oedema—Ramipril—type 2 diabetes mellitus	0.000111	0.000541	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000111	0.000541	CcSEcCtD
Rivaroxaban—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000111	0.00054	CcSEcCtD
Rivaroxaban—Pain—Losartan—type 2 diabetes mellitus	0.000111	0.00054	CcSEcCtD
Rivaroxaban—Constipation—Losartan—type 2 diabetes mellitus	0.000111	0.00054	CcSEcCtD
Rivaroxaban—Rash—Gliclazide—type 2 diabetes mellitus	0.00011	0.000535	CcSEcCtD
Rivaroxaban—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00011	0.000535	CcSEcCtD
Rivaroxaban—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.00011	0.000534	CcSEcCtD
Rivaroxaban—Urticaria—Irbesartan—type 2 diabetes mellitus	0.00011	0.000533	CcSEcCtD
Rivaroxaban—Shock—Ramipril—type 2 diabetes mellitus	0.00011	0.000532	CcSEcCtD
Rivaroxaban—Headache—Gliclazide—type 2 diabetes mellitus	0.00011	0.000532	CcSEcCtD
Rivaroxaban—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000109	0.000531	CcSEcCtD
Rivaroxaban—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000109	0.00053	CcSEcCtD
Rivaroxaban—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000109	0.000528	CcSEcCtD
Rivaroxaban—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000109	0.000527	CcSEcCtD
Rivaroxaban—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000108	0.000526	CcSEcCtD
Rivaroxaban—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000107	0.00052	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000106	0.000516	CcSEcCtD
Rivaroxaban—Dizziness—Valsartan—type 2 diabetes mellitus	0.000106	0.000516	CcSEcCtD
Rivaroxaban—Dizziness—Orlistat—type 2 diabetes mellitus	0.000105	0.00051	CcSEcCtD
Rivaroxaban—Asthenia—Metformin—type 2 diabetes mellitus	0.000105	0.00051	CcSEcCtD
Rivaroxaban—Hypotension—Ramipril—type 2 diabetes mellitus	0.000104	0.000506	CcSEcCtD
Rivaroxaban—Nausea—Gliclazide—type 2 diabetes mellitus	0.000104	0.000504	CcSEcCtD
Rivaroxaban—Pruritus—Metformin—type 2 diabetes mellitus	0.000104	0.000503	CcSEcCtD
Rivaroxaban—Urticaria—Losartan—type 2 diabetes mellitus	0.000103	0.000501	CcSEcCtD
Rivaroxaban—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000103	0.000499	CcSEcCtD
Rivaroxaban—Vomiting—Valsartan—type 2 diabetes mellitus	0.000102	0.000496	CcSEcCtD
Rivaroxaban—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000102	0.000494	CcSEcCtD
Rivaroxaban—Rash—Valsartan—type 2 diabetes mellitus	0.000101	0.000492	CcSEcCtD
Rivaroxaban—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000101	0.000491	CcSEcCtD
Rivaroxaban—Vomiting—Orlistat—type 2 diabetes mellitus	0.000101	0.00049	CcSEcCtD
Rivaroxaban—Headache—Valsartan—type 2 diabetes mellitus	0.000101	0.000489	CcSEcCtD
Rivaroxaban—Diarrhoea—Metformin—type 2 diabetes mellitus	0.0001	0.000486	CcSEcCtD
Rivaroxaban—Rash—Orlistat—type 2 diabetes mellitus	0.0001	0.000486	CcSEcCtD
Rivaroxaban—Dermatitis—Orlistat—type 2 diabetes mellitus	0.0001	0.000486	CcSEcCtD
Rivaroxaban—Headache—Orlistat—type 2 diabetes mellitus	9.95e-05	0.000483	CcSEcCtD
Rivaroxaban—Dyspnoea—Ramipril—type 2 diabetes mellitus	9.94e-05	0.000482	CcSEcCtD
Rivaroxaban—Asthenia—Irbesartan—type 2 diabetes mellitus	9.91e-05	0.000481	CcSEcCtD
Rivaroxaban—Dyspepsia—Ramipril—type 2 diabetes mellitus	9.81e-05	0.000476	CcSEcCtD
Rivaroxaban—Pruritus—Irbesartan—type 2 diabetes mellitus	9.77e-05	0.000474	CcSEcCtD
Rivaroxaban—Dizziness—Metformin—type 2 diabetes mellitus	9.68e-05	0.00047	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	9.62e-05	0.000467	CcSEcCtD
Rivaroxaban—Fatigue—Ramipril—type 2 diabetes mellitus	9.61e-05	0.000466	CcSEcCtD
Rivaroxaban—Hypersensitivity—Losartan—type 2 diabetes mellitus	9.58e-05	0.000465	CcSEcCtD
Rivaroxaban—Nausea—Valsartan—type 2 diabetes mellitus	9.55e-05	0.000463	CcSEcCtD
Rivaroxaban—Constipation—Ramipril—type 2 diabetes mellitus	9.53e-05	0.000463	CcSEcCtD
Rivaroxaban—Diarrhoea—Irbesartan—type 2 diabetes mellitus	9.45e-05	0.000459	CcSEcCtD
Rivaroxaban—Nausea—Orlistat—type 2 diabetes mellitus	9.43e-05	0.000458	CcSEcCtD
Rivaroxaban—Asthenia—Losartan—type 2 diabetes mellitus	9.33e-05	0.000453	CcSEcCtD
Rivaroxaban—Vomiting—Metformin—type 2 diabetes mellitus	9.31e-05	0.000452	CcSEcCtD
Rivaroxaban—Rash—Metformin—type 2 diabetes mellitus	9.23e-05	0.000448	CcSEcCtD
Rivaroxaban—Dermatitis—Metformin—type 2 diabetes mellitus	9.22e-05	0.000448	CcSEcCtD
Rivaroxaban—Pruritus—Losartan—type 2 diabetes mellitus	9.2e-05	0.000446	CcSEcCtD
Rivaroxaban—Feeling abnormal—Ramipril—type 2 diabetes mellitus	9.19e-05	0.000446	CcSEcCtD
Rivaroxaban—Headache—Metformin—type 2 diabetes mellitus	9.17e-05	0.000445	CcSEcCtD
Rivaroxaban—Dizziness—Irbesartan—type 2 diabetes mellitus	9.14e-05	0.000443	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	9.12e-05	0.000442	CcSEcCtD
Rivaroxaban—Diarrhoea—Losartan—type 2 diabetes mellitus	8.9e-05	0.000432	CcSEcCtD
Rivaroxaban—Urticaria—Ramipril—type 2 diabetes mellitus	8.86e-05	0.00043	CcSEcCtD
Rivaroxaban—Abdominal pain—Ramipril—type 2 diabetes mellitus	8.81e-05	0.000428	CcSEcCtD
Rivaroxaban—Vomiting—Irbesartan—type 2 diabetes mellitus	8.78e-05	0.000426	CcSEcCtD
Rivaroxaban—Rash—Irbesartan—type 2 diabetes mellitus	8.71e-05	0.000423	CcSEcCtD
Rivaroxaban—Dermatitis—Irbesartan—type 2 diabetes mellitus	8.7e-05	0.000422	CcSEcCtD
Rivaroxaban—Nausea—Metformin—type 2 diabetes mellitus	8.7e-05	0.000422	CcSEcCtD
Rivaroxaban—Headache—Irbesartan—type 2 diabetes mellitus	8.65e-05	0.00042	CcSEcCtD
Rivaroxaban—Dizziness—Losartan—type 2 diabetes mellitus	8.6e-05	0.000417	CcSEcCtD
Rivaroxaban—Vomiting—Losartan—type 2 diabetes mellitus	8.27e-05	0.000401	CcSEcCtD
Rivaroxaban—Hypersensitivity—Ramipril—type 2 diabetes mellitus	8.21e-05	0.000399	CcSEcCtD
Rivaroxaban—Nausea—Irbesartan—type 2 diabetes mellitus	8.21e-05	0.000398	CcSEcCtD
Rivaroxaban—Rash—Losartan—type 2 diabetes mellitus	8.2e-05	0.000398	CcSEcCtD
Rivaroxaban—Dermatitis—Losartan—type 2 diabetes mellitus	8.19e-05	0.000397	CcSEcCtD
Rivaroxaban—Headache—Losartan—type 2 diabetes mellitus	8.14e-05	0.000395	CcSEcCtD
Rivaroxaban—Asthenia—Ramipril—type 2 diabetes mellitus	8e-05	0.000388	CcSEcCtD
Rivaroxaban—Pruritus—Ramipril—type 2 diabetes mellitus	7.89e-05	0.000383	CcSEcCtD
Rivaroxaban—Nausea—Losartan—type 2 diabetes mellitus	7.72e-05	0.000375	CcSEcCtD
Rivaroxaban—Diarrhoea—Ramipril—type 2 diabetes mellitus	7.63e-05	0.00037	CcSEcCtD
Rivaroxaban—Dizziness—Ramipril—type 2 diabetes mellitus	7.37e-05	0.000358	CcSEcCtD
Rivaroxaban—Vomiting—Ramipril—type 2 diabetes mellitus	7.09e-05	0.000344	CcSEcCtD
Rivaroxaban—Rash—Ramipril—type 2 diabetes mellitus	7.03e-05	0.000341	CcSEcCtD
Rivaroxaban—Dermatitis—Ramipril—type 2 diabetes mellitus	7.02e-05	0.000341	CcSEcCtD
Rivaroxaban—Headache—Ramipril—type 2 diabetes mellitus	6.98e-05	0.000339	CcSEcCtD
Rivaroxaban—Nausea—Ramipril—type 2 diabetes mellitus	6.62e-05	0.000321	CcSEcCtD
Rivaroxaban—CYP3A5—Metabolism—CBS—type 2 diabetes mellitus	2.14e-05	0.000223	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	2.11e-05	0.00022	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	2.1e-05	0.000219	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	2.09e-05	0.000217	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PPARG—type 2 diabetes mellitus	2.08e-05	0.000216	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—COX2—type 2 diabetes mellitus	2.06e-05	0.000214	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—SLC5A2—type 2 diabetes mellitus	2.06e-05	0.000214	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—AKT1—type 2 diabetes mellitus	2.06e-05	0.000214	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—SLC5A4—type 2 diabetes mellitus	2.05e-05	0.000213	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—MAT1A—type 2 diabetes mellitus	2.05e-05	0.000213	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—INS—type 2 diabetes mellitus	2.04e-05	0.000212	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—NCOA6—type 2 diabetes mellitus	2.02e-05	0.000211	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	2.01e-05	0.000209	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—HSD11B1—type 2 diabetes mellitus	1.99e-05	0.000207	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—UCP2—type 2 diabetes mellitus	1.99e-05	0.000207	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—UCP3—type 2 diabetes mellitus	1.99e-05	0.000207	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ND1—type 2 diabetes mellitus	1.98e-05	0.000206	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ENPP1—type 2 diabetes mellitus	1.98e-05	0.000206	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—G6PC—type 2 diabetes mellitus	1.98e-05	0.000206	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.98e-05	0.000206	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HBA2—type 2 diabetes mellitus	1.98e-05	0.000206	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GCGR—type 2 diabetes mellitus	1.92e-05	0.0002	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—type 2 diabetes mellitus	1.91e-05	0.000199	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PCK1—type 2 diabetes mellitus	1.87e-05	0.000195	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ALB—type 2 diabetes mellitus	1.87e-05	0.000194	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	1.84e-05	0.000192	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—OXCT1—type 2 diabetes mellitus	1.81e-05	0.000189	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CYTB—type 2 diabetes mellitus	1.81e-05	0.000189	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.78e-05	0.000186	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—NOS3—type 2 diabetes mellitus	1.78e-05	0.000186	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	1.77e-05	0.000185	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—SRD5A1—type 2 diabetes mellitus	1.76e-05	0.000184	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	1.75e-05	0.000183	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—HK1—type 2 diabetes mellitus	1.75e-05	0.000182	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	1.73e-05	0.00018	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GCKR—type 2 diabetes mellitus	1.69e-05	0.000176	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—LPA—type 2 diabetes mellitus	1.69e-05	0.000176	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—HSD3B2—type 2 diabetes mellitus	1.69e-05	0.000176	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—KCNJ11—type 2 diabetes mellitus	1.69e-05	0.000176	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HSD17B3—type 2 diabetes mellitus	1.68e-05	0.000175	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—STAR—type 2 diabetes mellitus	1.68e-05	0.000175	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ACACA—type 2 diabetes mellitus	1.68e-05	0.000175	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.68e-05	0.000175	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	1.66e-05	0.000173	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PTGS2—type 2 diabetes mellitus	1.63e-05	0.00017	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ALDOB—type 2 diabetes mellitus	1.62e-05	0.000169	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ABCC8—type 2 diabetes mellitus	1.61e-05	0.000168	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CBS—type 2 diabetes mellitus	1.61e-05	0.000168	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—COX2—type 2 diabetes mellitus	1.55e-05	0.000162	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—SLC5A2—type 2 diabetes mellitus	1.55e-05	0.000162	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	1.54e-05	0.000161	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—NCOA6—type 2 diabetes mellitus	1.53e-05	0.000159	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	1.51e-05	0.000158	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	1.51e-05	0.000158	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GLP1R—type 2 diabetes mellitus	1.51e-05	0.000157	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	1.5e-05	0.000157	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HSD11B1—type 2 diabetes mellitus	1.5e-05	0.000156	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—UCP2—type 2 diabetes mellitus	1.5e-05	0.000156	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—UCP3—type 2 diabetes mellitus	1.5e-05	0.000156	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1.45e-05	0.000151	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	1.44e-05	0.00015	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.43e-05	0.000149	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.43e-05	0.000149	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	1.43e-05	0.000149	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PCK1—type 2 diabetes mellitus	1.41e-05	0.000147	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—SLC2A2—type 2 diabetes mellitus	1.41e-05	0.000146	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	1.38e-05	0.000144	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	1.38e-05	0.000144	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CPT1A—type 2 diabetes mellitus	1.38e-05	0.000143	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—MTR—type 2 diabetes mellitus	1.38e-05	0.000143	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.37e-05	0.000142	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	1.35e-05	0.000141	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—NAMPT—type 2 diabetes mellitus	1.35e-05	0.000141	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—LIPC—type 2 diabetes mellitus	1.34e-05	0.00014	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—HBA1—type 2 diabetes mellitus	1.34e-05	0.00014	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GCK—type 2 diabetes mellitus	1.34e-05	0.00014	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CYP11A1—type 2 diabetes mellitus	1.33e-05	0.000139	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HK1—type 2 diabetes mellitus	1.32e-05	0.000138	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—SLC9A1—type 2 diabetes mellitus	1.31e-05	0.000136	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CETP—type 2 diabetes mellitus	1.3e-05	0.000135	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.29e-05	0.000135	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	1.29e-05	0.000134	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—KCNJ11—type 2 diabetes mellitus	1.28e-05	0.000133	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HSD3B2—type 2 diabetes mellitus	1.28e-05	0.000133	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GCKR—type 2 diabetes mellitus	1.28e-05	0.000133	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—LPA—type 2 diabetes mellitus	1.28e-05	0.000133	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.26e-05	0.000131	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.26e-05	0.000131	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ALDOB—type 2 diabetes mellitus	1.22e-05	0.000127	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.22e-05	0.000127	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.22e-05	0.000127	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.22e-05	0.000127	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.22e-05	0.000127	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.22e-05	0.000127	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PSMD6—type 2 diabetes mellitus	1.2e-05	0.000125	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—SREBF1—type 2 diabetes mellitus	1.2e-05	0.000125	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—SNAP25—type 2 diabetes mellitus	1.2e-05	0.000125	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CTGF—type 2 diabetes mellitus	1.18e-05	0.000123	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.18e-05	0.000123	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—HMGCR—type 2 diabetes mellitus	1.17e-05	0.000122	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.17e-05	0.000121	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ADRA2A—type 2 diabetes mellitus	1.15e-05	0.000119	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	1.14e-05	0.000118	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	1.12e-05	0.000116	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	1.12e-05	0.000116	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CYP2E1—type 2 diabetes mellitus	1.1e-05	0.000115	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.09e-05	0.000114	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—SLC2A1—type 2 diabetes mellitus	1.09e-05	0.000113	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CYP1A2—type 2 diabetes mellitus	1.09e-05	0.000113	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	1.09e-05	0.000113	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CYP3A4—type 2 diabetes mellitus	1.06e-05	0.000111	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	1.06e-05	0.000111	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GCG—type 2 diabetes mellitus	1.04e-05	0.000109	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—SLC2A4—type 2 diabetes mellitus	1.04e-05	0.000109	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	1.04e-05	0.000108	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	1.04e-05	0.000108	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	1.04e-05	0.000108	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	1.04e-05	0.000108	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	1.04e-05	0.000108	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	1.02e-05	0.000106	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	1.01e-05	0.000106	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	1.01e-05	0.000106	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	1.01e-05	0.000106	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	1.01e-05	0.000105	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	9.94e-06	0.000104	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	9.94e-06	0.000104	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	9.89e-06	0.000103	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	9.77e-06	0.000102	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	9.6e-06	0.0001	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	9.57e-06	9.97e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	9.57e-06	9.97e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	9.4e-06	9.79e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	9.24e-06	9.62e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	9.24e-06	9.62e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	9.24e-06	9.62e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	9.09e-06	9.46e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	9.09e-06	9.46e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	9.09e-06	9.46e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GNB3—type 2 diabetes mellitus	9e-06	9.37e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PPARGC1A—type 2 diabetes mellitus	9e-06	9.37e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—HMOX1—type 2 diabetes mellitus	8.96e-06	9.33e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	8.92e-06	9.29e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	8.84e-06	9.21e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CAT—type 2 diabetes mellitus	8.84e-06	9.21e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	8.69e-06	9.05e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	8.66e-06	9.03e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	8.65e-06	9.01e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—APOB—type 2 diabetes mellitus	8.58e-06	8.94e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GSTM1—type 2 diabetes mellitus	8.35e-06	8.69e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	8.31e-06	8.66e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	8.22e-06	8.56e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	8.22e-06	8.56e-05	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—AKT1—type 2 diabetes mellitus	8.2e-06	8.55e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—LPL—type 2 diabetes mellitus	8.19e-06	8.53e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	8.13e-06	8.47e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ADCY5—type 2 diabetes mellitus	8.02e-06	8.35e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	8.01e-06	8.35e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GPX1—type 2 diabetes mellitus	7.99e-06	8.33e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	7.88e-06	8.21e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	7.88e-06	8.21e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	7.86e-06	8.18e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	7.86e-06	8.18e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	7.86e-06	8.18e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	7.86e-06	8.18e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CD36—type 2 diabetes mellitus	7.78e-06	8.11e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PPP2CA—type 2 diabetes mellitus	7.69e-06	8.01e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	7.53e-06	7.85e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	7.38e-06	7.68e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	7.24e-06	7.54e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	7.01e-06	7.3e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	7e-06	7.29e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	6.89e-06	7.18e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	6.87e-06	7.15e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.79e-06	7.07e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	6.79e-06	7.07e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	6.79e-06	7.07e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	6.76e-06	7.04e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	6.67e-06	6.95e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	6.54e-06	6.81e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	6.47e-06	6.74e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	6.4e-06	6.67e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	6.4e-06	6.67e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	6.3e-06	6.56e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	6.28e-06	6.54e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	6.24e-06	6.5e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	6.24e-06	6.5e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	6.24e-06	6.5e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	6.2e-06	6.46e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	6.18e-06	6.44e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	6.09e-06	6.35e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	6.05e-06	6.3e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	6.03e-06	6.28e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	6.02e-06	6.27e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	5.98e-06	6.23e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	5.87e-06	6.12e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	5.87e-06	6.11e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	5.8e-06	6.04e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	5.6e-06	5.83e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	5.6e-06	5.83e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	5.6e-06	5.83e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	5.57e-06	5.8e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	5.49e-06	5.72e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	5.46e-06	5.69e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	5.45e-06	5.67e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	5.38e-06	5.6e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	5.33e-06	5.55e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	5.29e-06	5.51e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	5.2e-06	5.42e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	5.18e-06	5.4e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	5.14e-06	5.36e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	5.14e-06	5.36e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	5.12e-06	5.34e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	5.12e-06	5.33e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	5.06e-06	5.27e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	5.06e-06	5.27e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	4.85e-06	5.06e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	4.85e-06	5.06e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	4.71e-06	4.9e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	4.51e-06	4.7e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—INS—type 2 diabetes mellitus	4.43e-06	4.61e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.18e-06	4.36e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	4.18e-06	4.36e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	4.16e-06	4.34e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	4.11e-06	4.28e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	4.06e-06	4.23e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	3.99e-06	4.15e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	3.88e-06	4.04e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	3.88e-06	4.04e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	3.88e-06	4.04e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	3.81e-06	3.97e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	3.73e-06	3.88e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	3.72e-06	3.87e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	3.62e-06	3.77e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	3.57e-06	3.72e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	3.55e-06	3.7e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	3.43e-06	3.57e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	3.36e-06	3.5e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	3.26e-06	3.39e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	3.2e-06	3.34e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	3.19e-06	3.33e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	3.16e-06	3.29e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.78e-06	2.9e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.73e-06	2.84e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.5e-06	2.6e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.39e-06	2.49e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.39e-06	2.49e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	2.36e-06	2.46e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	2.19e-06	2.28e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1.78e-06	1.86e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.1e-06	1.15e-05	CbGpPWpGaD
